Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
23 studies found for:    Open Studies | "Giant Cell Arteritis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Biomarkers in Giant Cells Arteritis
Condition: Giant Cells Arteritis
Interventions: Behavioral: Clinical evaluation;   Other: Paraclinical evaluation;   Device: Imaging;   Other: Ophthalmologic examination;   Biological: Dosage of biomarkers
2 Recruiting Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Interventions: Drug: Sirukumab;   Drug: Placebo to match sirukumab;   Drug: Prednisone;   Drug: Placebo to match prednisone
3 Not yet recruiting Giant Cell Arteritis and Anakinra Trial
Condition: Giant Cell Arteritis
Interventions: Drug: PLACEBO;   Drug: ANAKINRA
4 Not yet recruiting Giant Cell Arteritis: Improving Use of Ultrasound Evaluation
Condition: Giant Cell Arteritis
Intervention: Device: Ultrasound of temporal and axillary arteries
5 Recruiting Study of Circulating Microparticles in Giant Cell Arteritis
Conditions: Giant Cell Arteritis;   Acute Phase
Intervention: Other: Blood sample
6 Recruiting Prospective Follow-up Study of the Aortic Diameter in Patients With Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention:
7 Recruiting Determining Disease Activity Biomarkers in Individuals With Giant Cell Arteritis
Condition: Temporal Arteritis
Intervention:
8 Not yet recruiting Aetiology of TemporaL Arteritis Study
Condition: Temporal Arteritis
Intervention:
9 Recruiting Validation of a Diagnostic Algorithm of Giant Cell Arteritis
Condition: Giant Cell Arteritis
Intervention: Other: color Doppler ultrasound and TAB in case of CDU negative
10 Unknown  Efficacy of Micro-Pulse Steroid Therapy as Induction Therapy in Patients With Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Interventions: Drug: Betamethasone;   Drug: isotonic sodium chloride solution (placebo)
11 Not yet recruiting Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica
Condition: Polymyalgia Rheumatica
Interventions: Drug: Sirukumab;   Drug: Placebo to match sirukumab;   Drug: Prednisone /Prednisone placebo
12 Not yet recruiting Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE
Condition: Polymyalgia Rheumatica
Interventions: Drug: Tocilizumab;   Drug: Placebo
13 Recruiting Improving the Diagnosis and Prognostication of GCA Through the Novel Use of PET Scan and Immune Biomarkers
Condition: Giant Cell Arteritis
Intervention:
14 Recruiting Study of Phenotypic and Functional Characteristics of Regulatory T Lymphocytes in Horton's Disease
Condition: Horton's Disease
Intervention: Biological: Blood samples
15 Unknown  Study of the T CD8 Immune Response in Horton's Disease
Condition: Horton's Disease
Interventions: Other: Blood sample drawn into a 5 mL dry tube at the diagnosis and after 3 months of treatment;   Other: 16 blood samples drawn into 6 mL heparinized tubes at the diagnosis and after 3 months of treatment;   Other: Blood sample drawn into a 5 mL dry tube;   Other: 16 blood samples drawn into 6 mL heparinized tubes
16 Unknown  Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)
Conditions: Horton's Disease;   Infectious Disease;   Neoplasia;   Solid Tumor;   Hemopathy
Interventions: Other: 1 blood sample;   Other: 2 to 3 blood samples (at inclusion, at 3 months and at 6 months in cases of relapse)
17 Unknown  Diagnostic Study of Temporal Arteritis
Condition: Temporal Arteritis
Intervention:
18 Unknown  Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis
Conditions: Temporal Arteritis;   Duplex of Temporal Artery;   Biopsy of Temporal Artery
Intervention: Procedure: biopsy of temporal artery
19 Recruiting One-Time DNA Study for Vasculitis
Conditions: Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss);   Giant Cell Arteritis;   Granulomatosis With Polyangiitis (Wegener's);   Microscopic Polyangiitis;   Polyarteritis Nodosa;   Takayasu's Arteritis
Intervention:
20 Recruiting American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
Conditions: Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg Strauss Syndrome;   Polyarteritis Nodosa;   Giant Cell Arteritis;   Takayasu Arteritis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Indicates status has not been verified in more than two years